Arista stock is in focus with earnings due May 5. This options strategy aims to generate a robust return from the networking equipment maker.
In a volatile market, investors can put themselves on the right path by focusing on companies with durable competitive advantages.
Amphastar Pharmaceuticals is rated a Buy, with ~81% upside to a $33 fair value, despite margin pressures for 2026. AMPH faces declining sales in legacy products but expects mid- to high-single-digit ...
Investors in Cboe Global Markets Inc (Symbol: CBOE) saw new options begin trading today, for the April 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CBOE ...